AEP vs AKAM Stock Comparison
Scores Breakdown
| Metric | AEP | AKAM |
|---|---|---|
| 📈 Growth | 12/30 | 22/30 |
| 💰 Profitability | 14/20 | 17/20 |
| 🏦 Financial Health | 14/20 | 17/20 |
| 💵 Valuation | 15/20 | 16/20 |
| ⚠️ Risk (lower is better) | 5/10 | 4/10 |
| Overall Score | 60/100 | 78/100 |
Side-by-Side Summaries
| AEP Analysis | AKAM Analysis |
|---|---|
📈 Growth & Financial TrajectoryAcross the 8 quarters, Revenues rose from about $4.70B (2024 Q3) to $5.45B (2026 Q2), a ~16% gain, but with volatility (peak around $6.01B in 2025 Q3 and dips in several quarters). Net income ranged from about $0.92B (2024 Q3) to a high of about $1.29B (2025 Q2), ending near $0.75B in 2026 Q2. The trajectory shows modest top-line growth with mixed earnings momentum; the end result is below the initial earnings level despite higher revenue. 💰 Margins & Cash FlowOperating margins have generally trended in the mid-20s percent across several quarters (roughly mid-20s in 2024 Q4 and 2025 Q3; about 23% in 2026 Q2). Cash flow from operations remained positive in most periods (roughly $1.2B–$1.9B), while investing activities were sizable and often negative, pressuring overall free cash flow. Net cash flow patterns reflect ongoing capital spending typical of a regulated utility. 🛡️ Balance Sheet & LiquidityTotal assets run around $110B–$122B with equity in the $27B–$33B range and long-term debt near $42B–$50B. Liabilities exceed current assets in several quarters, yielding weaker near-term liquidity (current ratio often below 1). Still, a large asset base and regulated cash flows provide resilience, with debt levels offset by steady rate recovery. ⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryOver the 8 quarters, AKAM's revenues rose from about $1.00B to about $1.10B, a modest expansion of ~9-10%, with a steady uptrend across quarters. Net income moved from roughly $58M in 2024-Q3 to a peak of about $140M in 2025-Q3, before printing around $79M in 2026-Q2, reflecting quarterly volatility but positive trajectory. 💰 Margins & Cash FlowGross margin stayed robust in the mid-to-high 50s% (Q2 2026 ~55.8%; Q4 2025 ~58.6%; Q3 2025 ~59.2%). Operating income remained positive in every quarter shown. Operating cash flow (continuing) was solid, e.g., around $326M in 2026-Q2. Net cash flow turned positive in 2026-Q2 at roughly $0.85B, with investing cash outflows offset by financing inflows in several quarters, indicating healthy cash generation despite capex. 🛡️ Balance Sheet & LiquidityAssets near $15.1B in 2026-Q2, liabilities around $10.3B, and equity about $4.75B. Current assets vs current liabilities yield a comfortable liquidity cushion (approx. 1.6x). Leverage remains moderate with substantial noncurrent assets and conservative equity backing. ⚠️ Key Drivers & Risks
|